Evanson Jeff 4
4 · Outlook Therapeutics, Inc. · Filed Feb 25, 2021
Insider Transaction Report
Form 4
Evanson Jeff
Chief Commercial Officer
Transactions
- Sale
Common Stock
2021-02-23$2.09/sh−8,554$17,861→ 1,141,930 total
Footnotes (1)
- [F1]These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 25% of the shares as provided in that certain Consulting Agreement dated January 27, 2020.